ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for MRSN

Stock NameMersana Therapeutics Inc
TickerMRSN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS59045L1061
LEI529900VWD5VDZ7PVOS22

Show aggregate MRSN holdings

News associated with MRSN

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives $56.60 Average Target Price from Brokerages
Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have been given a consensus rating of “Buy” by the six analysts that are presently covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have covered the stock in […] - 2025-08-27 02:07:07
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average […] - 2025-07-30 02:30:59
Brokerages Set Mersana Therapeutics, Inc. (NASDAQ:MRSN) Price Target at $5.20
Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) has earned an average recommendation of “Buy” from the seven analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The […] - 2025-07-08 02:56:44
Brokerages Set Mersana Therapeutics, Inc. (NASDAQ:MRSN) Price Target at $5.20
Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) has earned an average recommendation of “Buy” from the seven analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The […] - 2025-07-08 02:21:48
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives $5.20 Average Price Target from Brokerages
Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have been given an average rating of “Buy” by the seven analysts that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation […] - 2025-06-13 02:14:50
Bank of America Corp DE Has $1.36 Million Holdings in Mersana Therapeutics, Inc. (NASDAQ:MRSN)
Bank of America Corp DE cut its stake in Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) by 3.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 953,952 shares of the company’s stock after selling 36,084 shares during the quarter. Bank […] - 2025-06-06 04:34:57
Millennium Management LLC Boosts Stake in Mersana Therapeutics, Inc. (NASDAQ:MRSN)
Millennium Management LLC grew its position in shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) by 206.4% during the fourth quarter, Holdings Channel reports. The fund owned 795,973 shares of the company’s stock after purchasing an additional 536,190 shares during the period. Millennium Management LLC’s holdings in Mersana Therapeutics were worth $1,138,000 as of […] - 2025-06-05 04:25:03
Short Interest in Mersana Therapeutics, Inc. (NASDAQ:MRSN) Increases By 21.4%
Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) was the target of a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 12,780,000 shares, an increase of 21.4% from the April 30th total of 10,530,000 shares. Approximately 11.7% of the shares of the stock are […] - 2025-06-04 05:22:49
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Shares Sold by Two Sigma Advisers LP
Two Sigma Advisers LP trimmed its position in shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) by 8.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 448,000 shares of the company’s stock after selling 38,800 shares during the period. Two Sigma Advisers LP’s holdings in Mersana Therapeutics were worth $641,000 at the end […] - 2025-06-04 04:48:48
Deutsche Bank AG Sells 756,449 Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN)
Deutsche Bank AG cut its stake in Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) by 47.4% during the fourth quarter, HoldingsChannel reports. The fund owned 839,724 shares of the company’s stock after selling 756,449 shares during the quarter. Deutsche Bank AG’s holdings in Mersana Therapeutics were worth $1,201,000 as of its most recent SEC filing. […] - 2025-05-26 05:04:45
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives Average Recommendation of “Buy” from Brokerages
Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have been given a consensus rating of “Buy” by the seven analysts that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy […] - 2025-05-21 05:09:00
Truist Financial Raises Mersana Therapeutics (NASDAQ:MRSN) Price Target to $10.00
Mersana Therapeutics (NASDAQ:MRSN – Free Report) had its price target lifted by Truist Financial from $9.00 to $10.00 in a research note issued to investors on Friday,Benzinga reports. They currently have a buy rating on the stock. MRSN has been the topic of several other reports. Guggenheim reissued a “buy” rating and issued a $5.00 […] - 2025-05-19 02:52:53
Barclays PLC Has $262,000 Holdings in Mersana Therapeutics, Inc. (NASDAQ:MRSN)
Barclays PLC cut its holdings in Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) by 63.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 182,711 shares of the company’s stock after selling 311,805 shares during the quarter. Barclays PLC’s holdings in Mersana Therapeutics were worth $262,000 at the end of the most recent reporting […] - 2025-05-12 04:30:56
Renaissance Technologies LLC Acquires 113,566 Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN)
Renaissance Technologies LLC lifted its holdings in shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) by 23.0% during the 4th quarter, Holdings Channel reports. The firm owned 606,285 shares of the company’s stock after purchasing an additional 113,566 shares during the quarter. Renaissance Technologies LLC’s holdings in Mersana Therapeutics were worth $867,000 at the […] - 2025-05-02 05:54:49
XTX Topco Ltd Reduces Stock Holdings in Mersana Therapeutics, Inc. (NASDAQ:MRSN)
XTX Topco Ltd trimmed its position in Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) by 81.7% during the 4th quarter, HoldingsChannel reports. The firm owned 63,530 shares of the company’s stock after selling 283,725 shares during the period. XTX Topco Ltd’s holdings in Mersana Therapeutics were worth $91,000 as of its most recent filing with […] - 2025-04-30 05:31:04
ExodusPoint Capital Management LP Buys Shares of 194,153 Mersana Therapeutics, Inc. (NASDAQ:MRSN)
ExodusPoint Capital Management LP bought a new position in shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 194,153 shares of the company’s stock, valued at approximately $278,000. ExodusPoint Capital Management LP […] - 2025-04-14 04:46:54
Los Angeles Capital Management LLC Sells 29,900 Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN)
Los Angeles Capital Management LLC lowered its holdings in Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) by 15.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 159,760 shares of the company’s stock after selling 29,900 shares during the […] - 2025-03-05 08:46:57
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives $5.57 Consensus Price Target from Analysts
Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) has earned an average rating of “Moderate Buy” from the nine brokerages that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the company. The […] - 2025-02-19 04:12:53
China Universal Asset Management Co. Ltd. Buys Shares of 26,194 Mersana Therapeutics, Inc. (NASDAQ:MRSN)
China Universal Asset Management Co. Ltd. purchased a new stake in shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 26,194 shares of the company’s stock, valued at approximately $37,000. A number of other hedge funds have also […] - 2025-02-05 06:46:56

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) MRSN holdings

DateNumber of MRSN Shares HeldBase Market Value of MRSN SharesLocal Market Value of MRSN SharesChange in MRSN Shares HeldChange in MRSN Base ValueCurrent Price per MRSN Share HeldPrevious Price per MRSN Share Held
2025-12-18 (Thursday)3,432USD 99,871MRSN holding increased by 137USD 99,8710USD 137 USD 29.0999 USD 29.06
2025-12-17 (Wednesday)3,432MRSN holding decreased by -40USD 99,734MRSN holding decreased by -1110USD 99,734-40USD -1,110 USD 29.06 USD 29.0449
2025-12-16 (Tuesday)3,472MRSN holding decreased by -8USD 100,844MRSN holding increased by 1351USD 100,844-8USD 1,351 USD 29.0449 USD 28.5899
2025-12-15 (Monday)3,480MRSN holding increased by 16USD 99,493MRSN holding increased by 1289USD 99,49316USD 1,289 USD 28.5899 USD 28.3499
2025-12-12 (Friday)3,464USD 98,204MRSN holding increased by 415USD 98,2040USD 415 USD 28.3499 USD 28.2301
2025-12-11 (Thursday)3,464MRSN holding increased by 16USD 97,789MRSN holding increased by 866USD 97,78916USD 866 USD 28.2301 USD 28.1099
2025-12-10 (Wednesday)3,448USD 96,923MRSN holding decreased by -104USD 96,9230USD -104 USD 28.1099 USD 28.1401
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MRSN by Blackrock for IE00BYXG2H39

Show aggregate share trades of MRSN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-17SELL-4029.19028.550 28.614USD -1,145 5.45 Loss of -926 on sale
2025-12-16SELL-829.12028.375 28.450USD -228 5.35 Loss of -185 on sale
2025-12-15BUY1628.80028.280 28.332USD 453 5.25
2025-12-11BUY1628.41028.100 28.131USD 450 5.05
2025-12-04BUY16028.36027.310 27.415USD 4,386 4.55
2025-12-02BUY12027.69327.361 27.394USD 3,287 4.34
2025-11-28BUY827.58027.300 27.328USD 219 4.13
2025-11-26BUY2427.85027.250 27.310USD 655 3.92
2025-11-26BUY2427.85027.250 27.310USD 655 3.92
2025-11-25BUY4027.61027.270 27.304USD 1,092 3.81
2025-11-24BUY827.78527.150 27.213USD 218 3.70
2025-11-20SELL-3228.00027.260 27.334USD -875 3.49 Loss of -763 on sale
2025-11-19BUY827.95027.423 27.476USD 220 3.37
2025-11-18BUY4827.99027.500 27.549USD 1,322 3.26
2025-11-17BUY1628.05027.543 27.594USD 442 3.15
2025-11-14BUY828.12027.110 27.211USD 218 3.03
2025-11-12BUY88.8808.450 8.493USD 68 2.88
2025-11-10BUY88.7108.260 8.305USD 66 2.83
2025-11-06BUY88.8678.000 8.087USD 65 2.78
2025-11-04BUY89.0658.000 8.106USD 65 2.72
2025-10-30BUY409.6109.240 9.277USD 371 2.62
2025-10-29BUY169.56010.030 9.983USD 160 2.59
2025-10-22SELL-329.1909.990 9.910USD -317 2.40 Loss of -240 on sale
2025-10-20BUY1610.42010.420 10.420USD 167 2.32
2025-10-17BUY409.88010.765 10.677USD 427 2.28
2025-10-15BUY6410.53011.150 11.088USD 710 2.23
2025-10-09BUY889.0709.500 9.457USD 832 2.11
2025-10-06BUY248.2008.350 8.335USD 200 2.05
2025-10-03BUY568.2808.280 8.280USD 464 2.02
2025-10-02BUY88.0008.045 8.041USD 64 1.98
2025-09-30BUY167.7608.220 8.174USD 131 1.92
2025-09-26BUY167.5707.570 7.570USD 121 1.86
2025-09-25BUY167.1707.390 7.368USD 118 1.83
2025-09-18BUY87.3507.400 7.395USD 59 1.76
2025-09-17BUY247.1507.430 7.402USD 178 1.73
2025-09-11SELL-87.4707.531 7.525USD -60 1.60 Loss of -47 on sale
2025-09-10BUY167.3507.700 7.665USD 123 1.57
2025-09-05SELL-86.8207.250 7.207USD -58 1.47 Loss of -46 on sale
2025-08-29SELL-247.3207.850 7.797USD -187 1.33 Loss of -155 on sale
2025-08-27BUY167.6307.739 7.728USD 124 1.25
2025-08-26SELL-87.6507.710 7.704USD -62 1.21 Loss of -52 on sale
2025-08-25BUY87.6508.090 8.046USD 64 1.17
2025-08-20SELL-327.2907.392 7.382USD -236 1.09 Loss of -201 on sale
2025-08-18BUY167.3807.680 7.650USD 122 1.01
2025-08-08SELL-166.3006.600 6.570USD -105 0.83 Loss of -92 on sale
2025-08-05BUY87.0407.050 7.049USD 56 0.71
2025-08-01SELL-246.6006.801 6.781USD -163 0.63 Loss of -148 on sale
2025-07-30BUY326.7507.040 7.011USD 224 0.54
2025-07-28SELL-63,1776.8307.600 7.523USD -475,281 0.45 Loss of -446,811 on sale
2025-07-17SELL-4069.0759.450 9.412USD -3,821 0.46 Loss of -3,636 on sale
2025-07-11SELL-1,6248.6009.750 9.635USD -15,647 0.46 Loss of -14,901 on sale
2025-07-07BUY6097.6007.825 7.802USD 4,752 0.46
2025-07-02BUY11,0557.0007.250 7.225USD 79,872 0.47
2025-06-25BUY4028.7758.875 8.865USD 3,564 0.47
2025-06-11BUY4029.50010.750 10.625USD 4,271 0.48
2025-06-10BUY40210.17511.500 11.368USD 4,570 0.48
2025-06-04SELL-2019.2259.225 9.225USD -1,854 0.49 Loss of -1,756 on sale
2025-04-23BUY2019.75010.750 10.650USD 2,141 0.54
2025-04-10SELL-1,6166.5257.550 7.448USD -12,035 0.56 Loss of -11,122 on sale
2025-04-08SELL-2027.3258.425 8.315USD -1,680 0.57 Loss of -1,564 on sale
2025-04-07SELL-2027.6258.275 8.210USD -1,658 0.58 Loss of -1,542 on sale
2025-04-04SELL-1,0107.5758.275 8.205USD -8,287 0.58 Loss of -7,699 on sale
2025-04-01BUY8088.3509.100 9.025USD 7,292 0.59
2025-03-31SELL-6068.6009.500 9.410USD -5,702 0.59 Loss of -5,342 on sale
2025-03-14SELL-3,23211.62512.000 11.963USD -38,663 0.63 Loss of -36,624 on sale
2025-03-07SELL-40413.60013.875 13.848USD -5,594 0.65 Loss of -5,333 on sale
2025-03-04SELL-20212.70013.350 13.285USD -2,684 0.66 Loss of -2,551 on sale
2025-02-25BUY40413.20014.250 14.145USD 5,715 0.68
2025-02-19SELL-20213.92515.000 14.893USD -3,008 0.69 Loss of -2,868 on sale
2025-02-13BUY60615.22516.375 16.260USD 9,854 0.71
2025-02-12BUY20216.12517.500 17.363USD 3,507 0.71
2025-02-11BUY80816.62517.600 17.503USD 14,142 0.71
2025-01-17BUY80815.47515.675 15.655USD 12,649 0.90
2025-01-16BUY80815.35016.200 16.115USD 13,021 0.95
2025-01-13SELL-40415.55018.700 18.385USD -7,428 1.18 Loss of -6,951 on sale
2025-01-08SELL-80832.50035.225 34.952USD -28,242 1.40 Loss of -27,110 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRSN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1911,420025,39945.0%
2025-09-186,174016,11938.3%
2025-09-1728,392035,82379.3%
2025-09-164,32797,87754.9%
2025-09-158,737017,12951.0%
2025-09-125,26053113,19639.9%
2025-09-116,325017,06237.1%
2025-09-1015,102027,41055.1%
2025-09-0928,312039,45671.8%
2025-09-0813,430027,27149.2%
2025-09-0516,292055,32529.4%
2025-09-047,706021,95435.1%
2025-09-0312,648023,06754.8%
2025-09-0212,245023,55052.0%
2025-08-2910,077020,14150.0%
2025-08-2810,471016,72962.6%
2025-08-275,05808,71058.1%
2025-08-2610,251021,68347.3%
2025-08-2523,972049,90648.0%
2025-08-2217,681043,86940.3%
2025-08-2187,6600112,42978.0%
2025-08-207,317014,38550.9%
2025-08-1917,636028,34562.2%
2025-08-1825,5092,24239,55364.5%
2025-08-1517,45146825,95667.2%
2025-08-1462,8626,150102,19461.5%
2025-08-1356,27413,396103,16054.6%
2025-08-1212,461021,48958.0%
2025-08-1123,6534046,96150.4%
2025-08-0820,83940939,63152.6%
2025-08-0722,446050,35344.6%
2025-08-0612,420022,41355.4%
2025-08-0529,5971343,62767.8%
2025-08-0411,704232,94435.5%
2025-08-0132,57023060,12454.2%
2025-07-3130,742052,96858.0%
2025-07-3044,65791764,65869.1%
2025-07-2961,5472,578105,14658.5%
2025-07-2884,4928,934144,42658.5%
2025-07-252,145,045205,9853,599,12759.6%
2025-07-242,514,044334,9065,787,87643.4%
2025-07-23804,96717,1132,855,61528.2%
2025-07-2297,3430608,59716.0%
2025-07-21380,922199,1671,315,94228.9%
2025-07-18442,0162,080995,75044.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy